A human mutant CD4 molecule resistant to HIV-1 binding restores helper T-lymphocyte functions in murine CD4-deficient mice.
- Author:
Dong Ku KIM
1
;
Satoko TAHARA-HANAOKA
;
Nobukata SHINOHARA
;
Hiromitsu NAKAUCHI
Author Information
1. Cell and Gene Therapy Research Institute, College of Medicine, Pochon CHA University, CHA General Hospital, Seoul 135-081, Korea. dokukim@cha.ac.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
antigens, CD4;
aquired immunodefiency syndrome;
CD4-positive T-lymphocytes;
HIV-1;
mice, transgenic;
T-lymphocytes, helper-inducer
- MeSH:
*Virus Internalization;
T-Lymphocytes, Helper-Inducer/*metabolism/*virology;
Protein Binding;
Mutation/genetics;
Mice, Transgenic;
Mice;
Humans;
HIV-1/*metabolism;
HIV Envelope Protein gp120/metabolism;
Antigens, CD4/*genetics/*metabolism;
Animals
- From:Experimental & Molecular Medicine
2007;39(1):1-7
- CountryRepublic of Korea
- Language:English
-
Abstract:
CD4 is a cell surface glycoprotein that acts as a co-receptor for the T cell antigen receptor by binding to a non-polymorphic portion of MHC molecules. CD4 also functions as a receptor for human immunodeficiency virus type-I (HIV-1) because the viral envelope glycoprotein gp120 binds to CD4 with a high affinity. We have previously demonstrated that introduction of mutations into CD4 abolished the binding of gp120 and prevented HIV-1 from entering cells and spreading. However, whether introduction of such mutations into CD4 causes decreased binding to MHC and loss of function is yet to be determined. We generated transgenic mouse lines by injecting a mutant human CD4 (muthCD4) gene under a murine CD4 enhancer/promoter to ensure tissue and stage specific expression. To exclude the influence of endogenous murine CD4, transgenic mice were crossed with murine CD4-targeted mice to produce muthCD4 transgenic mice lacking endogenous CD4 (muthCD4TG/KO mice). In these mice, T lymphocytes expressing muthCD4 expanded and matured in the thymus and were present in the spleen and lymph nodes. They also activated B cells to mount an antibody response to a T-dependent antigen. The results from this study suggest that a human variant of CD4 modified to be resistant to HIV-1 binding can rescue the signaling for T cell development in the thymus in vivo, having helper T cell functions. Thus, further characterization of muthCD4 molecules should open the way to new HIV treatment modalities.
